Hester Pharmaceuticals Limited operates within the Biological products exc. diagnostic sector.
In addition to historical fundamental analyses, the complete report available to purchase compares Hester Pharmaceuticals Limited with three other
pharmaceutical manufacturers in Asia:
sales of 562.74 million Taiwanese Dollars [US$19.17 million]
of which 99%
was Finished Products Sales),
ISU Abxis Company Limited
of South Korea
(19.46 billion Korean Won [US$18.17 million]
of which 100%
was Antibody Medicine), and
Genmont Biotech Inc
based in Taiwan
(552.94 million Taiwanese Dollars [US$18.83 million]
During the year ended March of 2017, sales at
Hester Pharmaceuticals Limited were 1.23 billion Indian Rupees (US$18.79 million).
increase of 22.0%
versus 2016, when the company's sales were 1.01 billion Indian Rupees.
This was the fifth consecutive year of sales increases at Hester Pharmaceuticals Limited
(and since 2012, sales have increased a total of 155%).
Sales of Large Animal Health Production saw an increase
that was more than double the company's growth rate: sales were up
61.8% in 2017, from
93.94 million Indian Rupees to 152.03 million Indian Rupees.